Panacea Acquisition Corp (NUVB)

FINANCE: CORPORATE FINANCE
SIC: PHARMACEUTICAL PREPARATIONS

357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO, CA 94103

Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco.

Data as of 2021-08-02 09:15:44 -0400
Market Cap1.88 Billion Shares Outstanding217.65 Million Avg 30-day Volume410.099 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low15.23 / 8.15 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from NUVB instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 0 2 (0.12%) 0 (0.0%)
Funds Holding: 73 34 114.71% 43 (2.52%) 21 (1.22%) 104.76%
13F shares: 117.347 Million 11.773 Million 896.75% 65.451 Million 9.349 Million 600.08%
% Ownership 54.1644 79.2127 -31.62% 30.2104 62.9033 -51.97%
New Positions: 51 24 112.5% 30 15 100.0%
Increased Positions 12 3 300.0% 7 3 133.33%
Closed Positions 12 7 71.43% 8 5 60.0%
Reduced Positions 7 3 133.33% 5 2 150.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NUVB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NUVB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HANLEY DAVID C. CHIEF TECHNICAL OPERATIONS

  • Officer
0 2021-06-01 2

NODELMAN OLEG

ECOR1 CAPITAL, LLC

ECOR1 CAPITAL FUND, L.P.

ECOR1 CAPITAL FUND QUALIFIED, L.P.

ECOR1 VENTURE OPPORTUNITY FUND, LP

ECOR1 PANACEA HOLDINGS, LLC

BIOTECH OPPORTUNITY GP, LLC

  • Director
  • 10% Owner
13,711,517 2021-04-09 1

BAZEMORE ROBERT B

  • Director
5,000 2021-03-30 1

HUNG DAVID PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
390,225 2021-03-09 1

HASNAIN FAHEEM

  • Director
No longer subject to file 2021-02-10 1

COOPER GRAHAM K

  • Director
No longer subject to file 2021-02-10 1

BRADBURY DANIEL

  • Director
No longer subject to file 2021-02-10 1

SHARP SHALINI

  • Director
No longer subject to file 2021-02-10 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
NUVATION BIO INC NUVB 2021-08-03 14:45:04 UTC -0.7141 0.7741 80000
NUVATION BIO INC NUVB 2021-08-03 14:15:03 UTC -0.7141 0.7741 80000
NUVATION BIO INC NUVB 2021-08-03 13:45:03 UTC -0.7141 0.7741 80000
NUVATION BIO INC NUVB 2021-08-03 13:15:03 UTC -0.7141 0.7741 80000
NUVATION BIO INC NUVB 2021-08-03 12:45:03 UTC -0.7141 0.7741 80000
NUVATION BIO INC NUVB 2021-08-02 22:15:03 UTC -0.7141 0.7741 95000
NUVATION BIO INC NUVB 2021-08-02 21:45:03 UTC -0.7141 0.7741 95000
NUVATION BIO INC NUVB 2021-08-02 21:15:03 UTC -0.7141 0.7741 95000
NUVATION BIO INC NUVB 2021-08-02 20:45:03 UTC -0.7113 0.7713 95000
NUVATION BIO INC NUVB 2021-08-02 20:15:03 UTC -0.7113 0.7713 95000
NUVATION BIO INC NUVB 2021-08-02 19:45:03 UTC -0.7113 0.7713 95000
NUVATION BIO INC NUVB 2021-08-02 19:15:03 UTC -0.7113 0.7713 95000
NUVATION BIO INC NUVB 2021-08-02 18:45:03 UTC -0.703 0.763 95000
NUVATION BIO INC NUVB 2021-08-02 18:15:03 UTC -0.703 0.763 95000
NUVATION BIO INC NUVB 2021-08-02 17:45:03 UTC -0.703 0.763 95000
NUVATION BIO INC NUVB 2021-08-02 17:15:03 UTC -0.703 0.763 95000
NUVATION BIO INC NUVB 2021-08-02 16:45:03 UTC -0.7259 0.7859 95000
NUVATION BIO INC NUVB 2021-08-02 16:15:03 UTC -0.7259 0.7859 95000
NUVATION BIO INC NUVB 2021-08-02 15:45:03 UTC -0.7259 0.7859 95000
NUVATION BIO INC NUVB 2021-08-02 15:15:03 UTC -0.7259 0.7859 95000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments